EXEL News and Press, Exelixis Inc. From 01/05/26

2026-01-05 13:26:16 ET More on Exelixis Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day - Slideshow Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D...

VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy for early gastric and gastroesophageal junction cancers last month, ushering in a new clinical paradigm for patients with h...

2025-12-11 06:12:48 ET Exelixis, Inc. (EXEL) Discusses Strategic Approach to Building Next-Generation Oncology Franchises at R&D Day December 10, 2025 1:00 PM EST... Read the full article on Seeking Alpha For further details see: Exelixis, Inc. (EXEL) Discusses Strategic...

- Event to Review R&D Progress and Outline Exelixis’ Strategy for Building Next-generation Oncology Franchises - Exelixis, Inc. (Nasdaq: EXEL) today announced that it will webcast its virtual event, Exelixis 2025 R&D Day: Building Next-generation Oncology Franchis...

2025-12-01 20:06:00 ET Axsome Therapeutics (NASDAQ: AXSM) and Exelixis (NASDAQ: EXEL) are hardly the best-known players in the large biotech industry. Thankfully, they don't need to be so to have excellent prospects. Both of these relatively small drugmakers have a lot going...

2025-12-01 13:35:00 ET All’s Well. You probably would not have guessed it by the somewhat muted end-of-month return of (+.25%) on the S&P 500, but the market for the first time since April experienced some modest bouts of volatility. During the depth...

2025-11-25 10:40:54 ET This article is part of a series that provides an ongoing analysis of the changes made to Renaissance Technologies US stock portfolio on a quarterly basis. It is based on their 13F Form filed on 11/13/2025. Please check out our last article for the changes mad...

2025-11-21 11:15:29 ET More on markets Dividend Roundup: Nvidia, Home Depot, Nike, Johnson & Johnson, and more U.S. growth is set to reaccelerate in 2026, Apollo’s Slok notes Nasdaq and SGX forge a pathway for seamless U.S.–Singapore dual listings ...

2025-11-10 13:41:36 ET Exelixis, Inc. (EXEL) Guggenheim Securities 2nd Annual Healthcare Innovation Conference November 10, 2025 10:30 AM EST... Read the full article on Seeking Alpha For further details see: Exelixis, Inc. (EXEL) Presents at Guggenheim Securities 2nd Annual...

2025-11-06 21:39:00 ET Topline Summary and Update Read the full article on Seeking Alpha For further details see: Exelixis: The STELLAR Win Is A Mixed Bag, But Things Look Positive Still